Results for emodinamiċi translation from Maltese to English

emodinamiċi pulmonari
pulmonary haemodynamics

punti finali emodinamiċi
haemodynamic endpoints

kundizzjonijiet emodinamiċi li mhumiex stabbli,
unstable hemodynamic conditions.

pazjenti f’kundizzjonijiet emodinamiċi li mhumiex stabbli
patients in unstable hemodynamic conditions,

parametri emodinamiċi kienu assessjati fi stride- 1.
haemodynamic parameters were assessed in stride-1.

l-emodinamiċi kienu mkejla fi 17-il pazjent.
haemodynamics were measured in 17 patients.

ma kienux assessjati parametri emodinamiċi f' dawn l- istudji.
haemodynamic parameters were not assessed in these studies.

il-parametri emodinamiċi sistemiċi u l-ecgs ġew evalwati wkoll.
systemic haemodynamic parameters and ecgs were also evaluated.

il-parametri emodinamiċi invażivi kienu evalwati fl-ewwel studju biss.
invasive haemodynamic parameters were assessed in the first study only.

dawn ir-riżultati kienu konformi ma’ titjib fil-parametri emodinamiċi addizzjonali.
these findings were in accordance with improvements in additional haemodynamic parameters.

parametri emodinamiċi kienu assessjati fi stride-1 fuq pazjenti kemm fi klassi funzjonali ii kif ukoll fi klassi funzjonali iii.
haemodynamic parameters: these were assessed in stride-1 for both functional class ii and iii patients.

il-parametri invasivi emodinamiċi kienu mkejla fil-linja bażi u wara 12-il ġimgħa ta’ kura.
invasive haemodynamic parameters were assessed at baseline and after 12 weeks treatment.

dawn ir-riżultati kienu konformi ma’ titjib fil-parametri emodinamiċi addizzjonali (ara tabella 5).
these findings were in accordance with improvements in additional haemodynamic parameters (see table 5).

minnħabba li sevoflurane għandu solubilità baxxa fid-demm, dawn il-bidliet emodinamiċi jistgħu jiġru aktar malajr minn loppji oħra volatili.
due to sevoflurane’s low solubility in blood, these haemodynamic changes may occur more rapidly than with other volatile anaesthetics.

titjib fil-parametri emodinamiċi u kliniċi ġie osservat f’pazjenti b’pah wara l-waqfien ta’ dasatinib.
improvements in haemodynamic and clinical parameters have been observed in patients with pah following discontinuation of dasatinib.

minħabba li s- sevoflurane għandu solubilità baxxa fid- demm, dawn il- bidliet emodinamiċi jistgħu jiġru aktar malajr minn loppji oħra volatili.
due to sevoflurane's low solubility in blood, these haemodynamic changes may occur more rapidly than with other volatile anaesthetics.

21 għal dak fil- medda terapewtika klinika, ikkawżaw tnaqqis fil- parametri taċ- ċelluli ħomor tad- demm (eritroċiti, emoglobina, ematokrit), bidliet fl- emodinamiċi renali (żieda fin- nitrogen ta ’ l- urea u l - krejatinina fid- demm), kif ukoll żieda fil- potassium fis- serum f’ annimali normotensivi.
in preclinical safety studies, doses producing exposure comparable to that in the clinical therapeutic range caused reduced red cell parameters (erythrocytes, haemoglobin, haematocrit), changes in renal haemodynamics (increased blood urea nitrogen and creatinine), as well as increased serum potassium in normotensive animals.